24/7 On-Site ACLS Cardiac Monitoring
ES
Ibogaine Center Cancún
Medical Safety

Ibogaine for Alcoholism: Evidence, Risks and Why Detox Comes First

Ibogaine is being studied for alcohol use disorder, but it does not treat alcohol withdrawal and combining the two can be dangerous. What the research shows and how a safe protocol works.

Updated: 4 min read
Three people laughing and celebrating outdoors

Ibogaine has shown promise for reducing alcohol cravings, but it is not an alcohol detox, and the evidence is much more limited than for opioids. Alcohol withdrawal can cause seizures and delirium tremens and must be managed medically before ibogaine is ever considered. The best human data come from a Brazilian retrospective study in which 61% of 75 people treated for alcohol and drug dependence were abstinent at follow-up, and from animal research showing ibogaine reduces alcohol intake through a brain growth factor called GDNF.

Key takeaways

  • Ibogaine does not treat alcohol withdrawal. A separate medical detox comes first.
  • Alcohol withdrawal and heavy drinking lower magnesium and potassium, which increases ibogaine's cardiac risk.
  • In a Brazilian retrospective study of 75 people (alcohol, cocaine, crack and cannabis), 61% were abstinent at follow-up.
  • Animal studies show ibogaine reduces alcohol consumption by increasing GDNF in the brain's reward area.
  • A small dose-escalation trial in alcohol use disorder has been registered in Brazil; controlled results are still needed.

Why alcohol is different from opioids

With opioids, ibogaine is used to interrupt withdrawal itself. With alcohol, that would be dangerous. Alcohol withdrawal can cause tremors, high blood pressure, seizures and delirium tremens, which can be fatal. It is usually treated with medications that themselves need careful management.

Heavy drinking also affects the heart and liver, and commonly depletes magnesium and potassium. Low electrolytes and a stressed heart increase the risk that ibogaine's effect on the QT interval leads to an arrhythmia. That is why, for alcohol, detox and stabilization come first, and ibogaine, if appropriate, comes after.

What the research shows

Human studies

  • Brazil, 75 people (Schenberg et al., 2014): a retrospective study of patients treated with ibogaine plus psychotherapy for dependence on alcohol, cocaine, crack and cannabis, most using several substances. At follow-up, 61% were abstinent. People treated once reported a median of 5.5 months of abstinence; those treated more than once, 8.4 months. No serious adverse reactions or deaths were reported.
  • Brazil, registered trial: an open-label, escalating-dose study of ibogaine in alcohol use disorder with 12 patients, with placebo added in later groups, was registered on ClinicalTrials.gov (NCT03380728).
  • Veterans: in the Stanford veterans study, 15 of the 30 participants had alcohol use disorder. The study measured PTSD, mood and function rather than drinking, but it shows people with alcohol problems were treated safely under medical monitoring.

Animal research

In a 2005 study in the Journal of Neuroscience, ibogaine reduced alcohol intake in rats. The effect depended on GDNF, a growth factor in the brain's reward area: blocking GDNF blocked ibogaine's effect, and giving GDNF alone mimicked it. This offers a plausible mechanism, but animal results do not always translate to people.

Honest limitations

The human evidence for alcohol is retrospective, small and mixed with other substances. We do not have controlled trials showing ibogaine is better than established treatments for alcohol use disorder, such as naltrexone, acamprosate, therapy and mutual-help groups. Ibogaine for alcohol should be considered promising but experimental.

What a safe protocol looks like

  1. Medical evaluation: liver tests, electrolytes (magnesium and potassium), EKG and a review of drinking pattern and withdrawal history, including past seizures or delirium tremens.
  2. Medically supervised alcohol detox before ibogaine, if needed, in an appropriate medical setting.
  3. Stabilization: correcting electrolytes and allowing the body to recover. Medications used during detox must be fully cleared, because some interact with ibogaine.
  4. Ibogaine treatment with a physician on site and continuous cardiac monitoring.
  5. Aftercare: therapy, support groups and, where appropriate, relapse-prevention medication prescribed by your doctor.

At Ibogaine Center Cancún, our medical team reviews every alcohol case individually and will tell you if you need detox elsewhere first. Treatment includes an on-site cardiologist, continuous EKG telemetry, one-to-one ACLS nursing and a 90-day aftercare plan. Read about heart safety and the cost of the program.

See how treatment works, what is included and who can apply in our ibogaine program for alcohol dependence.

Frequently asked questions

Can ibogaine cure alcoholism?

No. Ibogaine is not a cure and is not approved for alcohol use disorder. Some studies suggest it may reduce cravings and support abstinence, but controlled trials are still needed.

Can ibogaine be used for alcohol detox?

No. Alcohol withdrawal must be treated medically before ibogaine. Using ibogaine during alcohol withdrawal increases the risk of seizures and heart rhythm problems.

How long do I need to be sober before ibogaine?

It depends on your drinking history, withdrawal symptoms, lab results and the medications used during detox. Our medical team defines this after evaluating you.

I drink and use other drugs. Can ibogaine help?

Many people treated in the studies used several substances. Each one changes the protocol, so all substances and medications must be disclosed during your evaluation.

What if I have liver damage?

Ibogaine is processed by the liver. Significant liver disease may make treatment unsafe. Liver tests are part of the screening.

References

  • Schenberg, E. E. et al. "Treating drug dependence with the aid of ibogaine: a retrospective study." Journal of Psychopharmacology, 2014;28(11):993–1000. PubMed
  • He, D.-Y. et al. "Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption." Journal of Neuroscience, 2005. PubMed
  • "Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial." ClinicalTrials.gov NCT03380728.

Struggling with alcohol? Our medical team will review your situation confidentially and tell you honestly whether ibogaine is safe for you, and what needs to happen first. Request your evaluation.

Start Your Confidential Medical Screening

Our medical team reviews every case individually before treatment is considered.

All articles